BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37395026)

  • 21. Identification of two novel mutations on CLCN7 gene in a patient with malignant ostopetrosis.
    Bonapace G; Moricca MT; Talarico V; Graziano F; Pensabene L; Miniero R
    Ital J Pediatr; 2014 Nov; 40():90. PubMed ID: 25410126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of induced pluripotent stem cells (ARO-iPSC1-11) from a patient with autosomal recessive osteopetrosis harboring the c.212+1G>T mutation in SNX10 gene.
    Xu M; Stattin EL; Murphy M; Barry F
    Stem Cell Res; 2017 Oct; 24():51-54. PubMed ID: 29034896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of a gene-corrected human isogenic line (UAMi006-A) from propionic acidemia patient iPSC with an homozygous mutation in the PCCB gene using CRISPR/Cas9 technology.
    Fulgencio-Covián A; Álvarez M; Pepers BA; López-Márquez A; Ugarte M; Pérez B; van Roon-Mom WMC; Desviat LR; Richard E
    Stem Cell Res; 2020 Dec; 49():102055. PubMed ID: 33128956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision Medicine: Genetic Repair of Retinitis Pigmentosa in Patient-Derived Stem Cells.
    Bassuk AG; Zheng A; Li Y; Tsang SH; Mahajan VB
    Sci Rep; 2016 Jan; 6():19969. PubMed ID: 26814166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice.
    Alam I; Gerard-O'Riley RL; Acton D; Hardman SL; Murphy M; Alvarez MB; Blosser RJ; Sinn A; Srour EF; Kacena MA; Econs MJ
    FASEB J; 2022 Sep; 36(9):e22471. PubMed ID: 35959867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
    Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
    Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rescue of premature aging defects in Cockayne syndrome stem cells by CRISPR/Cas9-mediated gene correction.
    Wang S; Min Z; Ji Q; Geng L; Su Y; Liu Z; Hu H; Wang L; Zhang W; Suzuiki K; Huang Y; Zhang P; Tang TS; Qu J; Yu Y; Liu GH; Qiao J
    Protein Cell; 2020 Jan; 11(1):1-22. PubMed ID: 31037510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient gene correction of an aberrant splice site in β-thalassaemia iPSCs by CRISPR/Cas9 and single-strand oligodeoxynucleotides.
    Xiong Z; Xie Y; Yang Y; Xue Y; Wang D; Lin S; Chen D; Lu D; He L; Song B; Yang Y; Sun X
    J Cell Mol Med; 2019 Dec; 23(12):8046-8057. PubMed ID: 31631510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a gene corrected human isogenic iPSC line (CPGHi001-A-1) from a hearing loss patient with the TMC1 p.M418K mutation using CRISPR/Cas9.
    Wang H; Luo Y; Li J; Guan J; Yang S; Wang Q
    Stem Cell Res; 2022 Apr; 60():102736. PubMed ID: 35247837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
    Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
    Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of two isogenic knockout PKD2 iPS cell lines, IRFMNi003-A-1 and IRFMNi003-A-2, using CRISPR/Cas9 technology.
    Trionfini P; Ciampi O; Romano E; Benigni A; Tomasoni S
    Stem Cell Res; 2020 Jan; 42():101667. PubMed ID: 31830647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient introduction of an isogenic homozygous mutation to induced pluripotent stem cells from a hereditary hearing loss family using CRISPR/Cas9 and single-stranded donor oligonucleotides.
    Dong Y; Peng T; Wu W; Tan D; Liu X; Xie D
    J Int Med Res; 2019 Apr; 47(4):1717-1730. PubMed ID: 30819013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system.
    Wattanapanitch M; Damkham N; Potirat P; Trakarnsanga K; Janan M; U-Pratya Y; Kheolamai P; Klincumhom N; Issaragrisil S
    Stem Cell Res Ther; 2018 Feb; 9(1):46. PubMed ID: 29482624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells.
    Yingjun X; Yuhuan X; Yuchang C; Dongzhi L; Ding W; Bing S; Yi Y; Dian L; Yanting X; Zeyu X; Nengqing L; Diyu C; Xiaofang S
    Ann Hematol; 2019 Dec; 98(12):2661-2671. PubMed ID: 31495903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR/Cas9 Mediated Therapeutic Approach in Huntington's Disease.
    Alkanli SS; Alkanli N; Ay A; Albeniz I
    Mol Neurobiol; 2023 Mar; 60(3):1486-1498. PubMed ID: 36482283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of 3 clones of induced pluripotent stem cells (iPSCs) from a patient affected by Autosomal Recessive Osteopetrosis due to mutations in TCIRG1 gene.
    Lanzi G; Ferraro RM; Masneri S; Piovani G; Barisani C; Sobacchi C; Villa A; Vezzoni P; Giliani S
    Stem Cell Res; 2020 Jan; 42():101660. PubMed ID: 31794943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases.
    Ye T; Duan Y; Tsang HWS; Xu H; Chen Y; Cao H; Chen Y; Fu AKY; Ip NY
    Commun Biol; 2021 Feb; 4(1):195. PubMed ID: 33580208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generating an iPSC line (with isogenic control) from the PBMCs of an ACTA1 (p.Gly148Asp) nemaline myopathy patient.
    Houweling PJ; Coles CA; Tiong CF; Nielsen B; Graham A; McDonald P; Suter A; Piers AT; Forbes R; Ryan MM; Howden SE; Lamandé SR; North KN
    Stem Cell Res; 2021 Jul; 54():102429. PubMed ID: 34157503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models.
    Alam I; Gray AK; Chu K; Ichikawa S; Mohammad KS; Capannolo M; Capulli M; Maurizi A; Muraca M; Teti A; Econs MJ; Del Fattore A
    Bone; 2014 Feb; 59():66-75. PubMed ID: 24185277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.